Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 264INDUSTRY 159NIH 27OTHER_GOV 4NETWORK 4FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Plasma cell 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1

Interventions

fludarabine 5Cyclophosphamide 5Azacitidine 4Cytarabine 3venetoclax 2pegylated granulocyte colony-stimulating factor 2bisantrene 2Metformin 2Etoposide 2Dasatinib 2Clofarabine 2Busulfan 2vosaroxin 1treosulfan 1peginterferon alfa-2a 1nilotinib 1liposomal amphotericin B 1fludarabine phosphate 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1cc-486 1aldesleukin 1Zinc Sulfate 1Zinc 1Vitamin D 1Urination 1Tranexamic Acid 1Thiotepa 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Azacitidine × Other hematologic neoplasm × Clear all
NCT03493646 2024-05-28

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

Kirby Institute

Phase 2 Completed
40 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06256627 2024-02-13

The Maintenance Treatment of "ITIVA" in AML Patients

Henan Cancer Hospital

Phase NA Recruiting
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06105658 2023-10-30

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

Anhui Provincial Hospital

Phase 2 Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02275663 2015-01-06

Azacytidine Plus FLAG for Relapsed or Refractory AML

King Fahad Medical City

Phase 2 Unknown
37 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡